Københavns Universitet Nørregade 10 København K 1017 +45 35334470 line.kolle@adm.ku.dk www.indkoeb.ku.dk university Acquisition of an iQue screener Plus to PTH Screening Lab/BRIC. The iQue Screener Plus will be used as primary readout system at the newly established Program for Translational Hematology (PTH) Screening Lab. The system offers a new way to apply Flow Cytometry in a high throughput manner and will be used to screen various cancer drugs on hematological cancer patient samples. The technology allows for essential throughput and time and material savings that traditional Flow Cytometry instruments cannot achieve. 2000000.00 The iQue Screener Plus will be used as primary readout system at the newly established Program for Translational Hematology (PTH) Screening Lab. The system offers a new way to apply Flow Cytometry in a high throughput manner and will be used to screen various cancer drugs on hematological cancer patient samples. The technology allows for essential throughput and time and material savings that traditional Flow Cytometry instruments cannot achieve. The Biotech Research and Innovation Center (BRIC) is an elite research center at the Faculty of Health, Copenhagen University. It comprises 24 research groups within biomedical research and has a strong and long lasting cooperation with the Finsen Laboratory at Rigshospitalet. Recently, this cooperation lead to the establishment of a new research Program for Translational Hematology (PTH), which a. The instrument performs high throughput suspension screening using a flow cytometry based detector and produces multi-parameter, individual cell and bead measurements. The patented and proprietary technology of ‘air-gap-delimited’ sample separation allows for rapid low-volume measurements enabling multiplexed high throughput screening of samples in 96 and 384 well format. This technology is essential for high throughput analysis of primary cell material where the available numbers of cells is always a limiting factor. Other flow cytometry instruments are likely to require 10 times or more cells per analysed test condition as well as taking much longer time to do the analysis and are therefore not feasible to use for the intended application. The platform uses ForeCyt® software, the only acquisition and analysis software that provides a suite of sophisticated high throughput plate level analytics. There is no other instrument, which can perform high throughput suspension screening with limited primary cell material. 2017-09-26 IntelliCyt Corporation Albuquerque 2000000.00 Klagenævnet for udbud Dahlerups Pakhus, Langelinie Allé 17 Copenhagen Ø 2100 +45 35291000 klfu@erst.dk http://www.klfu.dk Konkurrence- og Forbrugerstyrelsen Carl Jacobsens Vej 35, Valby Copenhagen 2500 +45 41715000 kfst@kfst.dk http://www.kfst.dk 2017-09-26
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:382814-2017:TEXT:EN:HTML